Cordlife Group Limited

About

Cordlife Group Limited owns and operates five cord blood laboratories in Singapore, Hong Kong, India, Indonesia and the Philippines. Cordlife was the first cord blood bank in Singapore (May 2001) and amongst the first in Asia. Cordlife Group Limited has more than 12 years of cord blood banking experience as well as a published track record of cord blood transplants.

Labs and Locations

Cordlife Group Limited
1 Yishun Industrial Street 1 #06-01/09,
A'Posh Bizhub Singapore 768160

Business Experience

Cordlife Group Limited is listed on the Mainboard of the Singapore Exchange (SGX), and together with its subsidiaries, may be called "The Group". Cordlife Group Limited owns five cord blood banks in Singapore, Hong Kong, Indonesia, Philippines and India, and has a direct investment in China Cord Blood Corporation, one of the top banks in China. Cordlife also currently owns over 30% of Stemlife Malaysia. At present the laboratories in Singapore, Hong Kong, and India are accredited by AABB (formerly known as American  Association of Blood Banks), meeting the gold standard of private cord blood banking. The Group now comprises of:

Cordlife Group Limited - Singapore
Cordlife (Hong Kong) Limited - Hong Kong & Macau
Cordlife Sciences India Pvt Limited - Kolkata, India
PT Cordlife Persada - Jakarta, Indonesia
Cordlife Medical Philippines, Inc. - Manila, Philippines

Cordlife Group Limited was established in Singapore in 2001 to provide a full suite of cord blood and (subsequently) tissue banking services which include the collection, processing and cryopreservation of cord blood stem cells and umbilical cord tissue. Cordlife has grown rapidly from a fledging start-up company into a multi-national corporation. In 2005, Cordlife established its first overseas cord blood processing and storage facility in Hong Kong. The ISO certified facility, with a storage capacity for 50,000 cord blood and umbilical cord units, is Hong Kong’s largest and most advanced stem cell facility. In 2011, Cordlife introduced the patented technology, CellOptima™, which is exclusively available at Cordlife in Hong Kong, to isolate two types of stem cells from umbilical cord – Epithelial stem cells and Mesenchymal Stem Cells (MSC).

Collection Kit

The kit contains a closed system blood bag (brand JMS) that is pre-loaded with the anti-coagulant CPDA-1. The kit also provides the disinfectant Povidone-iodine.

Transportation Container

The collection kit is constructed with thermal insulation and validated to maintain room temperature for up to 48 hours during transportation back to the laboratory.

Shipping Info:

Cordlife provides dedicated staff to pick up the cord blood sample from Singapore hospitals upon notification.

Processing Method

Stem cells are separated from the cord blood using the fully automated and closed Sepax system from Biosafe. The final component is the buffy coat layer of the blood, which holds both white cells and stem cells.

Components Stored

Parents are provided with a report describing test results for the buffy coat holding white cells and stem cells including total nucleated cells (TNC), post processing sterility, viable CD34+ counts, as well as maternal blood infectious disease results.

Storage Method

Final cord blood storage is in 25 ml blood (cryo) bag encased in an overwrap. Blood samples are kept in a quarantine freezer, then moved to long term freezer after they pass testing. Stem cells are stored in the vapour phase of cryogenic nitrogen.

Licensing & Accreditation

Certified by Singapore Ministry of Health
Accredited by AABB

Clinical Experience

Cordlife Group Limited has released 11 client cords for therapy (6 autologous, 5 allogeneic)

Insurance

Cordlife clients will be covered by a program known as the Cordlife Care360 – a holistic program aimed to safeguard our client and their family.

1) Cordlife provides the coverage of possible pregnancy and childbirth complications*.
2) Cordlife will cover future storage payments if death or total permanent disability* occurs to either biological parent of Child during the contractual storage period.
3) Cordlife assures clients a cord blood unit of suitable match or US$25,000 to defray medical costs if the cord blood loses its viability at point of transplant*.
4) Cordlife will cover the cost for additional tests required in the event of a transplant* - matching (HLA resolution test) and viability (CFU assay).
5) Cordlife has taken additional insurance coverage, to safeguard client and their family from financial loss resulting from direct malpractice*.

* Terms and Conditions apply

Community Service

Free banking (terms and conditions apply) is given to families when a sibling has a diagnosis for which transplantation is standard therapy.
Special discounts are given to medical doctors and nurses.

Prices

Plan Type

Annual

Special Annual

10-Year

21-Year

At enrolment

 $             2,150.00

 $              1,280.00

 $              4,400.00

 $      6,400.00

Per Year

 $                 250.00

 $                  275.00

 $                  250.00

 NA

Year

2nd - 20th year

11th - 20th year

 NA

Additional Services

Cordlife has an exclusive license on patented technology to store stem cells from the lining of the umbilical cord. This cord lining contains both Epithelial Stem Cells (EpSC) and Mesenchymal Stem Cells (MSC). Parents who are banking cord blood can choose the enhanced services CordPlus (EpSCs + MSCs) or CordBasic plan (MSCs).